期刊文献+

232例胰腺癌回顾性分析 被引量:1

Retrospective analysis of 232 cases of pancreatic cancer
下载PDF
导出
摘要 目的总结诊疗经验以提高对胰腺癌的认识。方法回顾性分析2007年1月-2013年1月贵阳医学院附属医院收治的232例胰腺癌患者的临床资料,按其时间先后顺序将患者每三年分为一组,共建A、B两组,用统计学方法分析各组数据。同时还对所有患者的流行病学高危因素进行分析。结果术前解除胆道梗阻例数和所耗时间,根治性和姑息性手术例数和所耗时间,以及住院时间,A、B两组进行比较,P<0.005。术前营养支持例数和所耗时间,A、B两组比较,P>0.005。胰腺癌高危因素有吸烟、糖尿病、慢性胰腺炎和胆囊切除术后。结论术前积极准备,可以使根治性手术切除率提高。对有吸烟史、糖尿病、胆囊切除术后患者应注意追踪,尽可能完善检查,以提高诊断率。 [ Objective ] To improve understanding of pancreatic cancer by summing up the experiences of diag- nosis and treatment. [Methods] A retrospective analysis was conducted from January, 2007 to January, 2013 on a total of 232 the patients with pancreatic cancer in the Affiliated Hospital of Guiyang Medical College. Every three years can be divided into a group, to build A, B two groups, using statistical methods to analyze the clinical data. Besides analyzed the epidemiological risk factors for all patients. [ Results ] Comparing with A group and B group, included preoperative relieve biliary obstruction cases and time consuming, radical and palliative operation cases and time consuming, hospital stay, P 〈0.005. But in Preoperative nutritional support cases and time consuming, P 〉 0.005. The epidemiological risk factors of pancreatic cancer include smoking, diabetes, chronic pancreatitis and after cholecystectomy. [ Conclusions ] Active preoperative preparation can make the radical resection rate increase. Pay attention to the patients with smoking, diabetes, patients after choleeystectomy. As far as possible perfect inspection, then to improve the diagnostic rate.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第33期70-72,共3页 China Journal of Modern Medicine
基金 贵州省肝胆胰疾病研究科技创新人才团队(黔科合人才团队201041010)
关键词 胰腺癌 外科手术 流行病学 回顾性分析 pancreatic cancer surgical operation epidemiology retrospective analysis
  • 相关文献

参考文献14

  • 1JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics[J]. CA Cancer J Clin, 2008, 58(2): 71-96.
  • 2胰腺癌诊治指南[J].中华外科杂志,2007,45(19):1297-1299. 被引量:13
  • 3倪泉兴,虞先濬,刘亮.中国胰腺癌临床诊断标准的探讨[J].中国癌症杂志,2012,22(2):81-87. 被引量:59
  • 4孙诚谊,陈自力.重视胰腺癌的综合治疗[J].中华消化外科杂志,2009,8(4):244-246. 被引量:7
  • 5张群华,倪泉兴,代表中国抗癌协会胰腺癌专业委员会.胰腺癌2340例临床病例分析[J].中华医学杂志,2004,84(3):214-218. 被引量:141
  • 6UJIKI MB, TALAMONI MS. Surgical management of pancreatic- cancer[J]. Semin Radiat Oncol, 2005, 15(4): 218-225.
  • 7HIDALGO M. Pancretic cancer[J]. N Engl J, 2010, 362(17): 1605-1617.
  • 8WANG XL, WANG J. Smoking-gene interaction and distase de- velopment:relevamce to pancereatic cancer and atherosclerosis[J]. World J Surg, 2005, 29(3): 344-353.
  • 9PARKS RW, GARDEN OJ. Ensuring early diagnosis in pancereatic cancer[J]. Practitioner, 2000, 244 (1609): 336-338, 340-341.
  • 10CHAI ST, LEIBSON CL, RABE KG, et aL pancereatic cancer associated diabetes mellitus: prevalence and emporal association with diagnosis of cancer[J]. Gastro-enterology, 2008, 13 (1): 95-101.

二级参考文献107

  • 1Zou, Yi-Ping,Du, Ji-Dong,Li, Wei-Min,Xiao, Yin-Qi,Xu, Hong-Bin,Zheng, Fang,Huang, Hui,Liu, Hao-Run,Li, Hu-Cheng.Gallstone recurrence after successful percutaneous cholecystolithotomy:a 10-year follow-up of 439 cases[J].Hepatobiliary & Pancreatic Diseases International,2007,6(2):199-203. 被引量:43
  • 2赵玉沛,陈革.胰腺外科的新进展[J].消化外科,2006,5(2):77-80. 被引量:22
  • 3曾仲,王曙光,别平,陈耿,董家鸿.腹腔镜胆囊切除术后远期疗效评价(附3200例报告)[J].腹腔镜外科杂志,2006,11(4):344-345. 被引量:6
  • 4Egawa S, Takeda K, Fukuyama S, et al. Clinicopathological aspects of small pancreatic cancer. Pancreas,2004,28(3) :235 -240.
  • 5Hirai L, Kimura W, Ozawa K, et al. Perineural invasion in the pancreatic canced. Pancreas ,2002,24 ( 1 ) : 15 - 25.
  • 6Wagner M, Redaelli C, Lietz M, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg,2004,91 (5) :556 -594.
  • 7Ujiki MB, Talamonti MS. Surgical management of pancreatic cancer. Semin Radiat Oncol,2005,15 (4) :218 - 225.
  • 8Sa Cunha A, Rault A, Laurent C, et al. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg,2005,201 (3) :359 -365.
  • 9Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 1997,15 (6) :2403 - 2413.
  • 10Storniolo AM, Enas NH, Browm CA, et al. An investigational new drug treatment program for patients with gemcitabine : result for over 3000 patients with pancreatic carcinoma. Cancer, 1999,85 (6) :1261 - 1268.

共引文献249

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部